APTX
Aptinyx Inc

2,823
Loading...
Loading...
Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aptinyx Inc?
What is the 52-week high for Aptinyx Inc?
What is the 52-week low for Aptinyx Inc?
What is Aptinyx Inc stock price today?
What was Aptinyx Inc stock price yesterday?
What is the PE ratio of Aptinyx Inc?
What is the Price-to-Book ratio of Aptinyx Inc?
What is Aptinyx Inc's EBITDA?
What is the 50-day moving average of Aptinyx Inc?

Latest APTX News

View
No APTX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.